Ontex Group stock closed at €2.315 after a choppy few months, with the share price down roughly 20% over ninety days. The market has been wrestling with a simple question: is this just a cheap, troubled hygiene products producer or a deeply discounted turnaround story?
The latest half year results put that tension in sharp focus. Adjusted EBITDA for H1 2026 landed at €78m, with margins still under pressure and a large €144m impairment charge tied to a sweeping transformation review. The rest of this article unpacks what that means for the coming years.
Is Ontex Group a genuine value opportunity at a 0.1x P/S, or is that steep discount simply the market pricing in real balance sheet strain? Compare the current share price to detailed fair value work in the valuation analysis for Ontex Group
Prefer clear charts instead of another dense block of earnings details and impairment figures? Explore Ontex Group's full financial picture in the visual breakdown of its valuation in the company report for Ontex Group.
The bullish view on Ontex Group rests on contract driven volume visibility, a mix shift into Adult Care and a cost program that can lift margins and support deleveraging. The latest H1 2026 numbers show only partial progress on these milestones.
Contracted revenue did not prevent like for like sales from declining, which suggests those recent wins are so far only cushioning broader volume softness. Adult Care volumes grew about 1%, and baby pants delivered double digit growth, which is consistent with the idea of a slow pivot toward more resilient product lines. However, group adjusted EBITDA margin slipped to 9.1% and full year guidance of €165 to €180m implies no clear margin step up yet.
The Focus to Value program, with a €240m savings target through 2028, is the clearest concrete proof that management is acting on the margin and cash flow leg of the bull case.
Compare how Ontex Group frames this cost and mix shift story with what the street is pricing in right now. See the consensus price target analysis for Ontex Group to check whether analysts think the earnings path justifies the current share price.The bearish narrative on Ontex Group argues that weak Baby Care demand, margin pressure from private label exposure and heavy restructuring cash needs could cap earnings and keep leverage uncomfortable. The latest half year print largely lines up with that view. Like for like revenue fell about 2% and baby and feminine volumes declined about 4%. That supports the idea that structural softness in these categories is still weighing on the top line despite contract wins.
EBITDA margin slipped to 9.1% and adjusted EBITDA dropped to €78m while raw material and transport inflation intensified from March to June. That is exactly the margin squeeze bears highlighted. Guidance for full year adjusted EBITDA of €165m to €180m, with free cash flow expected to be between a €10m and €25m outflow, also reinforces the concern that the Focus to Value savings and footprint work are not yet offsetting cost and restructuring drag.
After interest cover concerns and a volatile Ontex Group share price, it is fair to ask whether these pressures are isolated or part of a wider pattern. Review the independent risk scoring to see what potential weak spots may have been overlooked in the risk analysis for Ontex Group which shows 2 important warning signs.If Ontex Group's mix of contract visibility, margin pressure and cost savings potential has you watching closely, register for free with Simply Wall St and add it to a Watchlist to track share price moves against fair value and watch for a more attractive entry point. Once you hold the stock, use the Portfolio Command Center to cut through market noise and focus on the key developments that matter for your returns. For a longer term view, tap into the Community to see how other investors are thinking about the same risks and catalysts. By spotting subtle shifts in fundamentals and sentiment early, you can react faster and stay a step ahead of the wider market.
Fresh ideas can move from quiet to breakout while you watch from the sidelines. Spot stocks building momentum under the radar for now and act now.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com